Schedule 13D ownership disclosure
AERIE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00771V108
Event date: 2015-03-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,837,466
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-15-000235
- Form type
- SC 13D
- Filer
- AERIE PHARMACEUTICALS INC
- CIK
- CIK 1337553
- Filed
- Apr 02, 2015
- Reporting period
- Mar 30, 2015
- Description
- Schedule 13D beneficial ownership